Asthma and COPD are typical breathing situations affecting a vast portion of the U.S. Population. The excessive occurrence and prevalence costs of these sicknesses have propelled the demand for pharmaceutical interventions, leading to a developing market for Asthma and COPD Drugs. The pharmaceutical industry has witnessed notable advancements in the development of inhalation gadgets and drug shipp